Dishman Pharma plans Rs.53 crore capexIllustrative image – not actual.

Dishman Pharmaceuticals & Chemicals is planning a capital expenditure programme of Rs.52.5 crore. The capex plan includes setting up of good manufacturing practices (GMP), an active pharmaceutical ingredients (API) plant and an research and development centre (R&D). The company is also expanding its existing facilities.

The company is planning to enter the capital market to raise Rs.53 crore through a public issue, opening on 29 March 2004.

← All latest storiesBack to top →